Rozlytrek 100 mg

Rozlytrek 100 mg capsules are a medication used to treat certain types of cancer. This oral treatment is designed to target specific genetic alterations in cancer cells.

Rozlytrek 100 mg capsules are primarily used in the treatment of advanced solid tumors that harbor specific genetic alterations. These alterations include NTRK gene fusions, ROS1-positive non-small cell lung cancer, and other rare genetic mutations. The medication is intended for patients who have a specific genetic marker that the drug can target, making it a precision medicine option.

Common effects of Rozlytrek 100 mg capsules may include fatigue, nausea, and constipation. Some patients may experience changes in taste, dizziness, or swelling in the arms and legs. These effects can vary from person to person and may not affect everyone who takes the medication.

Rozlytrek 100 mg capsules should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding the use of this medication. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider.

Rozlytrek 100 mg capsules may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.